| For: | Rzeniewicz K, Sharma R. Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease. World J Clin Oncol 2024; 15(11): 1394-1403 [PMID: 39582617 DOI: 10.5306/wjco.v15.i11.1394] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i11/1394.htm |
| Number | Citing Articles |
| 1 |
Xusheng Zhang, Wenyan Zhou, Bendong Chen, Qi Wang. Serum uric acid and the risk of MASLD in Americans: A cross-sectional study combined with Mendelian randomization and network toxicology analysis. Medicine 2026; 105(1): e46841 doi: 10.1097/MD.0000000000046841
|
| 2 |
Hongkun Yin, Xusheng Zhang, Qi Wang. Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02858-9
|
| 3 |
Yi-Fan Zou, Yi-Gang Zhang, Zi-Chu Zhao, Zheng Li, Hong-Da Liu, Qing-Ya Li, Ze-Tian Chen, Cheng-Jun Zhu, Hai-Tao Liu, Ji-Wei Wang, Feng-Yuan Li, Lin-Jun Wang, Dian-Cai Zhang, Li Yang, Hao Xu, Ze-Kuan Xu, Sen Wang. Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy. World Journal of Gastrointestinal Surgery 2025; 17(9): 106198 doi: 10.4240/wjgs.v17.i9.106198
Abstract(60) |
Core Tip(52) |
Full Article(HTML)(112)
|
Full Article with Cover (PDF)-2667K(39)
|
Audio-270K(7)
|
Peer-Review Report-231K(19)
|
Answering Reviewers-232K(22)
|
Supplementary Material-337K(37)
|
Full Article (PDF)-2267K(37)
|
Full Article (XML)-175K(21)
|
Times Cited (0)
|
Total Visits (1212)
|
Open
|
